Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 17 | 2022 | 6942 | 0.980 |
Why?
|
Colonic Neoplasms | 9 | 2021 | 2531 | 0.860 |
Why?
|
DNA Glycosylases | 2 | 2022 | 125 | 0.830 |
Why?
|
Esophageal Neoplasms | 4 | 2023 | 1661 | 0.690 |
Why?
|
Adenoma | 6 | 2020 | 2152 | 0.510 |
Why?
|
Aspirin | 4 | 2022 | 3134 | 0.430 |
Why?
|
Adenomatous Polyps | 1 | 2014 | 109 | 0.410 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6364 | 0.370 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1378 | 0.350 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 728 | 0.340 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2268 | 0.320 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 248 | 0.310 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2054 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 12 | 2023 | 18071 | 0.290 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.290 |
Why?
|
Precancerous Conditions | 1 | 2014 | 976 | 0.270 |
Why?
|
Genome-Wide Association Study | 12 | 2022 | 12807 | 0.260 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1884 | 0.240 |
Why?
|
Microsatellite Instability | 2 | 2020 | 728 | 0.220 |
Why?
|
ras Proteins | 3 | 2014 | 1053 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.210 |
Why?
|
Peptides | 1 | 2015 | 4331 | 0.210 |
Why?
|
Sulindac | 1 | 2002 | 29 | 0.200 |
Why?
|
Genomics | 4 | 2022 | 5929 | 0.190 |
Why?
|
Rectal Neoplasms | 2 | 2021 | 1182 | 0.180 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2014 | 220 | 0.180 |
Why?
|
Carcinoma, Verrucous | 1 | 2020 | 27 | 0.180 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13648 | 0.180 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 784 | 0.170 |
Why?
|
Genetic Variation | 4 | 2020 | 6610 | 0.160 |
Why?
|
DNA Polymerase II | 1 | 2020 | 104 | 0.160 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 145 | 0.160 |
Why?
|
Gap Junctions | 1 | 2020 | 229 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2021 | 16047 | 0.150 |
Why?
|
Genetic Loci | 2 | 2019 | 2631 | 0.150 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 157 | 0.150 |
Why?
|
Polyps | 1 | 2020 | 200 | 0.150 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 242 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 591 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 735 | 0.140 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 433 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4520 | 0.130 |
Why?
|
Drug Tolerance | 1 | 2018 | 363 | 0.130 |
Why?
|
Colon | 2 | 2021 | 1795 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 250 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 800 | 0.120 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2014 | 70 | 0.110 |
Why?
|
Crohn Disease | 2 | 2018 | 2283 | 0.110 |
Why?
|
Adrenomedullin | 1 | 2013 | 85 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2014 | 121 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2021 | 22223 | 0.110 |
Why?
|
DNA Helicases | 2 | 2020 | 852 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1153 | 0.110 |
Why?
|
Ampulla of Vater | 1 | 2014 | 150 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1242 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 510 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 312 | 0.100 |
Why?
|
Strongyloides stercoralis | 1 | 2012 | 23 | 0.100 |
Why?
|
Strongyloidiasis | 1 | 2012 | 27 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2014 | 288 | 0.100 |
Why?
|
Humans | 38 | 2023 | 765968 | 0.100 |
Why?
|
HTLV-I Infections | 1 | 2012 | 103 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2002 | 2844 | 0.100 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4108 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 1761 | 0.090 |
Why?
|
Prospective Studies | 7 | 2022 | 54802 | 0.090 |
Why?
|
Endoscopy, Digestive System | 1 | 2014 | 358 | 0.090 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2011 | 61 | 0.090 |
Why?
|
Jejunum | 1 | 2012 | 474 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.090 |
Why?
|
Male | 21 | 2023 | 363698 | 0.080 |
Why?
|
DNA Repair | 1 | 2019 | 2048 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2014 | 710 | 0.080 |
Why?
|
Aged | 15 | 2022 | 171117 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2018 | 2880 | 0.080 |
Why?
|
Neoplasms | 2 | 2016 | 22340 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12240 | 0.080 |
Why?
|
Disease Progression | 4 | 2023 | 13632 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1151 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2741 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1808 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2015 | 1751 | 0.070 |
Why?
|
Female | 20 | 2023 | 396112 | 0.070 |
Why?
|
Models, Genetic | 1 | 2018 | 3449 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8611 | 0.070 |
Why?
|
Genotype | 5 | 2021 | 13024 | 0.070 |
Why?
|
Genetic Markers | 1 | 2014 | 2601 | 0.070 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 388 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3111 | 0.070 |
Why?
|
Mutation | 2 | 2022 | 30198 | 0.070 |
Why?
|
Middle Aged | 17 | 2022 | 223009 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4348 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2015 | 1203 | 0.060 |
Why?
|
Software | 2 | 2018 | 4462 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2312 | 0.060 |
Why?
|
Odds Ratio | 4 | 2020 | 9649 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5337 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 862 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1892 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2900 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1915 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4772 | 0.050 |
Why?
|
Adult | 12 | 2023 | 223044 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2005 | 700 | 0.050 |
Why?
|
Genes, src | 1 | 2002 | 51 | 0.050 |
Why?
|
Septins | 1 | 2022 | 47 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3596 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59489 | 0.050 |
Why?
|
Colon, Descending | 1 | 2021 | 6 | 0.050 |
Why?
|
Colon, Ascending | 1 | 2021 | 14 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2942 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9601 | 0.050 |
Why?
|
Colon, Transverse | 1 | 2021 | 25 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11083 | 0.040 |
Why?
|
Risk Factors | 7 | 2023 | 74840 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39193 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2006 | 995 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 124 | 0.040 |
Why?
|
Cecum | 1 | 2021 | 232 | 0.040 |
Why?
|
3T3 Cells | 1 | 2002 | 1081 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6763 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1144 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 59889 | 0.040 |
Why?
|
Signal Transduction | 3 | 2020 | 23601 | 0.040 |
Why?
|
Genes, ras | 1 | 2002 | 658 | 0.040 |
Why?
|
Risk Assessment | 4 | 2023 | 24282 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 207 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5370 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2018 | 120 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2006 | 3513 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6897 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 342 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3236 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2878 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 370 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 396 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 366 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9373 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 399 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.030 |
Why?
|
Computational Biology | 2 | 2018 | 3559 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2631 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2858 | 0.030 |
Why?
|
Animals | 6 | 2020 | 168764 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12437 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14071 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 896 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4475 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6274 | 0.030 |
Why?
|
Transfection | 1 | 2002 | 5743 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9591 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3344 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3618 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29922 | 0.030 |
Why?
|
Transcription Factors | 2 | 2020 | 12131 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 114 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3946 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1247 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2411 | 0.020 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2012 | 143 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8297 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2016 | 1997 | 0.020 |
Why?
|
Telomerase | 1 | 2016 | 749 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2589 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 647 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1441 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6322 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 672 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 490 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2013 | 17075 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10729 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2796 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 544 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 577 | 0.020 |
Why?
|
Colectomy | 1 | 2014 | 697 | 0.020 |
Why?
|
Flavonoids | 1 | 2012 | 448 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8529 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3624 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1884 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4618 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5786 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10070 | 0.020 |
Why?
|
Research | 1 | 2016 | 1975 | 0.020 |
Why?
|
Pelvis | 1 | 2012 | 738 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1892 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4736 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2898 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3141 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10383 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81819 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5783 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2012 | 1069 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3797 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41649 | 0.010 |
Why?
|
Adolescent | 3 | 2020 | 88835 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14448 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2927 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6255 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7562 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15398 | 0.010 |
Why?
|
rho-Associated Kinases | 1 | 2006 | 291 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3655 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9338 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3615 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65188 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 743 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7421 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 618 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13266 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3715 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6209 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2710 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11022 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81514 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16721 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12976 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4137 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10429 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40065 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12403 | 0.010 |
Why?
|
Oxygen | 1 | 2005 | 4241 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17594 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15747 | 0.010 |
Why?
|
United States | 1 | 2019 | 72903 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9443 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20659 | 0.000 |
Why?
|